immunomedics biotechnology company focused development antibodydrug conjugates treatment cancer company acquired gilead immunomedics founded july david michael pehl named ceo december left due personal reasons february time dr behzad aghazadeh named executive october gilead sciences acquired march gilead announced closing former immunomedics facility morris plains httpsenwikipediaorgwikiimmunomedics